Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Atazanavir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 503Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus Cadila gets US FDA marketing approval for atazanavir capsules
    Zydus Cadila gets US FDA marketing approval for atazanavir capsules

    04 Jun 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=126630&sid=2

    PHARMABIZ
    04 Jun 2020
    Share Share
    Mylan Pharms Generic Atazanavir; Cobicistat Receives Tentative Approval in US
    Mylan Pharms Generic Atazanavir; Cobicistat Receives Tentative Approval in US

    28 Mar 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211124

    FDA
    28 Mar 2019
    Share Share
    EMA’s CHMP Recommends 6 New Meds, Releases Outcome of Sartan Investigation
    EMA’s CHMP Recommends 6 New Meds, Releases Outcome of Sartan Investigation

    01 Feb 2019

    // Ana Mulero RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/2/emas-chmp-recommends-six-new-medicines-releases?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%201%20February

    Ana Mulero RAPS
    01 Feb 2019
    Share Share
    Teva Announces Exclusive Launch of a Generic Version of Reyataz in the US
    Teva Announces Exclusive Launch of a Generic Version of Reyataz in the US

    28 Dec 2017

    // BIOSPACE

    https://www.biospace.com/article/releases/teva-announces-exclusive-launch-of-a-generic-version-of-reyataz-in-the-united-states/

    BIOSPACE
    28 Dec 2017
    Share Share
    Evotaz® (Atazanavir And Cobicistat): Gilead Sciences v. Mylan Pharmaceuticals
    Evotaz® (Atazanavir And Cobicistat): Gilead Sciences v. Mylan Pharmaceuticals

    15 Dec 2017

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/evotaz-atazanavir-and-cobicistat-gilead-sciences-v-mylan-pharmaceuticals-1513579409.pdf

    PATENT LITIGATION
    15 Dec 2017
    Share Share
    Mylan S.A.S. Gets EU Nod For Atazanavir
    Mylan S.A.S. Gets EU Nod For Atazanavir

    31 Jan 2017

    // EMA

    https://www.pharmacompass.com/pdf/news/mylan-sas-gets-eu-nod-for-atazanavir-1485942272.pdf

    EMA
    31 Jan 2017
    Share Share